Market Research Logo

Global Diabetic Nephropathy Market 2018-2022

Global Diabetic Nephropathy Market 2018-2022

About this market

Rise in incidence of diabetes to push growth in the market. Globally, there has been a rise in the incidence and prevalence of diabetes, which has resulted in the occurrence of chronic kidney disease in patients. Technavio’s analysts have predicted that the diabetic nephropathy market will register a CAGR of almost 34% by 2022.

Market Overview

Increasing incidence of diabetic nephropathy among diabetic patients

The incidence of diabetic nephropathy was observed to be much higher in freshly diagnosed cases of type 2 diabetes patients. The factors associated with the rise of incidence of nephropathy are hypertension, hypercholesterolemia, and obesity.

Growing economic burden of diabetic nephropathy

Diabetic nephropathy is a complication associated with diabetes mellitus. The cost associated with diabetic nephropathy increases gradually with the progression of disease due to the associated cost drivers such as dialysis and hospitalization.

For the detailed list of factors that will drive and challenge the growth of the diabetic nephropathy market during the 2018-2022, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Techman-Head Group and Brackett Aircraft Company the competitive environment is quite intense. Factors such as the increasing incidence of diabetic nephropathy among diabetic patients and the rise in incidence of diabetes, will provide considerable growth opportunities to diabetic nephropathy manufactures. AstraZeneca, Merck, and Sanofi are some of the major companies covered in this report.


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global metabolic disorder drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline drugs for diabetic nephropathy under Phase III stage of development
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global - Market size and forecast 2017-2022 ($ mn)
      • Table Global - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
  • Market segmentation by drug class
    • Segmentation by drug class
      • Table Drug class - Market share 2017-2022 (%)
    • Comparison by drug class
      • Table Comparison by drug class
    • ARBs - Market size and forecast 2017-2022
      • Table ARBs - Market size and forecast 2017-2022 ($ mn)
      • Table ARBs - Year-over-year growth 2018-2022 (%)
    • ACE inhibitors - Market size and forecast 2017- 2022
      • Table ACE inhibitors - Market size and forecast 2017-2022 ($ mn)
      • Table ACE inhibitors - Year-over-year growth 2018-2022 (%)
    • Others - Market size and forecast 2017-2022
      • Table Others - Market size and forecast 2017-2022 ($ mn)
      • Table Others - Year-over-year growth 2018-2022 (%)
    • Market opportunity by drug class
      • Table Market opportunity by drug class
  • Market segmentation by type of disease
    • Segmentation by type of disease
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ mn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Pipeline drugs in various stages of clinical trials for diabetic nephropathy
    • Market challenges
  • Market trends
    • Rise in incidence of diabetes
    • Increase in diabetic nephropathy-related cardiovascular mortality and end-stage renal disease
    • Multidisciplinary approach for the management of diabetic nephropathy
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AstraZeneca
      • Table AstraZeneca - Overview
      • Table AstraZeneca - Business segments
      • Table AstraZeneca - Organizational developments
      • Table AstraZeneca - Geographic focus
      • Table AstraZeneca - Key offerings
    • Merck
      • Table Merck - Overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck- Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
    • Sanofi
      • Table Sanofi - Overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report